4//SEC Filing
AMAG PHARMACEUTICALS INC. 4
Accession 0001179110-13-014017
CIK 0000792977operating
Filed
Sep 8, 8:00 PM ET
Accepted
Sep 9, 4:24 PM ET
Size
9.7 KB
Accession
0001179110-13-014017
Insider Transaction Report
Form 4
Deptula Barbara
Director
Transactions
- Award
Common Stock
2013-09-06+1,725→ 1,725 total - Award
Stock Option (Right to Buy)
2013-09-06+6,000→ 6,000 totalExercise: $24.82Exp: 2023-09-06→ Common Stock (6,000 underlying) - Award
Stock Option (Right to Buy)
2013-09-06+2,850→ 2,850 totalExercise: $24.82Exp: 2023-09-06→ Common Stock (2,850 underlying)
Footnotes (5)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock of AMAG Pharmaceuticals, Inc. (the "Issuer").
- [F2]These shares of common stock are issuable pursuant to a grant of restricted stock units pursuant to the Issuer's Third Amended and Restated 2007 Equity Incentive Plan (the "Plan") that vests in eight equal monthly installments commencing on October 1, 2013; however, delivery of the shares is deferred until the earlier of (a) three years from the date of grant and (b) the date of the director's separation from service to the Issuer.
- [F3]Not applicable.
- [F4]Grant of stock option pursuant to the Plan. This option vests and becomes exercisable in twenty-four equal monthly installments over two years from the date of grant.
- [F5]Grant of stock option pursuant to the Plan. This option vests and becomes exercisable in eight equal monthly installments commencing on October 1, 2013.
Documents
Issuer
AMAG PHARMACEUTICALS INC.
CIK 0000792977
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000792977
Filing Metadata
- Form type
- 4
- Filed
- Sep 8, 8:00 PM ET
- Accepted
- Sep 9, 4:24 PM ET
- Size
- 9.7 KB